# Exploratory Study of the Effects of Peptide PMS-001 on Long-Delay Recall in Patients With Moderate to Severe Dementia

> **NCT06946511** · PHASE1,PHASE2 · NOT_YET_RECRUITING · sponsor: **Ruijin Hospital** · enrollment: 50 (estimated)

## Conditions studied

- Dementia

## Interventions

- **DRUG:** Peptide PMS-001 Intravenous Injection
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06946511
- **Lead sponsor:** Ruijin Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-08-01
- **Primary completion:** 2026-01-31
- **Final completion:** 2026-01-31
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2025-05-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06946511

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06946511, "Exploratory Study of the Effects of Peptide PMS-001 on Long-Delay Recall in Patients With Moderate to Severe Dementia". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06946511. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*